Figure 1From: Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentFcgRIIa or FcgRIIIa genotypes alone are not prognostic of patient survival. Kaplan-Meier estimates of overall survival by (a) FcgRIIa-H131R and (b) FcgRIIIa-V158F genotypes. Survival time is presented in days after the first treatment with oncolytic adenovirus. Censored refers to patients who were still alive at the time of performing the analysis.Back to article page